Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Ironwood Pharmaceuticals Inc

IRWD
Current price
0.73 USD -0.023 USD (-3.11%)
Last closed 1.27 USD
ISIN US46333X1081
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 121 356 712 USD
Yield for 12 month -90.98 %
1Y
3Y
5Y
10Y
15Y
IRWD
21.11.2021 - 28.11.2021

Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally. It markets linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation, as well as for pediatric patients suffering from functional constipation under the LINZESS and CONSTELLA names. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; and Apraglutide, a long-acting synthetic peptide analog of glucagon-like peptide-2 for short bowel syndrome patients dependent on parenteral support, as well as for acute graft versus host disease. It has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts. Address: 100 Summer Street, Boston, MA, United States, 02110

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

3.34 USD

P/E ratio

72.67

Dividend Yield

Current Year

+351 410 000 USD

Last Year

+442 735 000 USD

Current Quarter

+90 545 000 USD

Last Quarter

+91 592 000 USD

Current Year

+351 410 000 USD

Last Year

+337 950 000 USD

Current Quarter

+90 545 000 USD

Last Quarter

+91 592 000 USD

Key Figures IRWD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 97 728 000 USD
Operating Margin TTM 34.86 %
Price to Earnings 72.67
Return On Assets TTM 14.56 %
PEG Ratio -0.26
Return On Equity TTM -574.72 %
Wall Street Target Price 3.34 USD
Revenue TTM 351 409 984 USD
Book Value -1.88 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -23.00 %
Dividend Yield
Gross Profit TTM 343 857 984 USD
Earnings per share 0.010 USD
Diluted Eps TTM 0.010 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY -77.30 %
Profit Margin 0.25 %

Dividend Analytics IRWD

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History IRWD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor 1194:1000
Payout Ratio
Last Split Date 02.04.2019

Stock Valuation IRWD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 72.67
Forward PE 12.33
Enterprise Value Revenue 1.79
Price Sales TTM 0.35
Enterprise Value EBITDA 6.27
Price Book MRQ 2.59

Financials IRWD

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators IRWD

For 52 weeks

0.59 USD 8.45 USD
50 Day MA 1.49 USD
Shares Short Prior Month 16 247 025
200 Day MA 3.77 USD
Short Ratio 3.87
Shares Short 11 250 189
Short Percent 13.30 %